07:00 , Apr 28, 2003 |  BioCentury  |  Finance

Ebb & Flow

Those who need a reminder of where the life science earnings growth is needn't look farther than last week's wave of biotech and pharma earnings. Outside of Pfizer (PFE) and specialty pharma play Forest (FRX),...
07:00 , Apr 21, 2003 |  BC Extra  |  Financial News

Acusphere raises $19 million

Acusphere raised more than $19 million in a first close of a venture round. The investors included Thomas Weisel Partners; BA Ventures; Burr, Egan Deleage; Polaris Venture Partners; BancBoston Ventures; HBM Bioventures; Audax Group; and...
07:00 , Jul 29, 2002 |  BioCentury  |  Finance

Ebb & Flow

Amgen's blockbuster second quarter earnings were driven by its homegrown products. In contrast, Enbrel, the rheumatoid arthritis drug acquired in the merger with Immunex , continued to have manufacturing problems that are leading patients to...
07:00 , Jul 24, 2002 |  BC Extra  |  Financial News

Acusphere raises $15 million

Microparticle technology company Acusphere (Watertown, Mass.) raised $15 million in a venture round led by Thomas Weisel. Other investors included BA Venture Partners; Polaris Venture Partners; Alta Ventures; MVI Medical Ventures; Prism Venture Partners; BancBoston...
07:00 , Jul 15, 2002 |  BioCentury  |  Finance

Ebb & Flow

Like any good shopper, Genentech (DNA) is keeping an eye on falling prices as part of its surveillance for potential M&A. The company has said for some time that M&A is part of its strategy,...
07:00 , Jul 12, 2002 |  BC Extra  |  Top Story

FleetBoston winding down Robbie

FleetBoston is winding down operations at its boutique investment firm Robertson Stephens, which it put up for sale in April when Fleet elected to refocus on core businesses such as personal financial services and wholesale...
07:00 , Apr 22, 2002 |  BioCentury  |  Finance

Ebb & Flow

Investors cleaning the mud off their boots from biotech's first quarter disasters breathed a sigh of relief after Trimeris delivered on one of the key milestones in the second quarter. TRMS announced Thursday that its...
07:00 , Apr 22, 2002 |  BioCentury  |  Finance

On the block . . . again

Robertson Stephens must be feeling a bit like the red-headed stepchild. News that FleetBoston Financial will sell the boutique investment firm means that Robbie will get its third "parent" in less than five years. In...
07:00 , Apr 16, 2002 |  BC Extra  |  Financial News

Syntonix raises $35.8 million

Syntonix Pharmaceuticals raised $35.8 million in a series B financing led by Bay City Capital and Alta Partners. Other investors included A.M. Pappas; Global Biomedical Partners; AFB Fund; Venrock Associates; BancBoston Ventures; Merrill Lynch Ventures;...
07:00 , Apr 16, 2002 |  BC Extra  |  Top Story

FleetBoston to sell Robertson Stephens

FleetBoston Financial said it will sell its boutique investment firm Roberston Stephens, which is focused on high-tech and biotech. FleetBoston said the sale of Roberston Stephens, and certain other businesses, reflects its effort to re-focus...